Geoff Meacham
Stock Analyst at Citi
(4.81)
# 447
Out of 4,478 analysts
1178
Total ratings
59.1%
Success rate
14.7%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $585 | $529.59 | +10.46% | 65 | Jul 7, 2026 | |
| MRNA Moderna | Maintained: Hold | $41 | $81.80 | -49.88% | 60 | Jun 26, 2026 | |
| PFE Pfizer | Maintained: Hold | $27 | $23.72 | +13.83% | 73 | Jun 25, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $120 | $114.76 | +4.57% | 18 | Jun 25, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $125 | $126.78 | -1.40% | 63 | Jun 23, 2026 | |
| ABBV AbbVie | Maintained: Buy | $230 | $254.76 | -9.72% | 65 | Jun 23, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $125 → $135 | $133.50 | +1.12% | 16 | Jun 23, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $700 | $649.81 | +7.72% | 58 | Jun 22, 2026 | |
| MANE Veradermics | Reiterated: Buy | $135 | $122.07 | +10.59% | 7 | Jun 22, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $165 | $129.61 | +27.30% | 79 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,500 | $1,200.06 | +24.99% | 98 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $24.49 | +124.58% | 2 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $66 | $56.70 | +16.40% | 70 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 | $56.92 | +15.95% | 25 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $131.50 | -1.14% | 11 | May 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $9.35 | -25.13% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 | $85.44 | -12.22% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $55.36 | +4.77% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $17.97 | +11.30% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $190 → $200 | $208.46 | -4.06% | 70 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $345 | $366.44 | -5.85% | 43 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $60 | $62.77 | -4.41% | 17 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $130 | $93.93 | +38.40% | 15 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $20.10 | +148.76% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $34.90 | +57.59% | 4 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.67 | +49.81% | 10 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 | $259.33 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.69 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $58.79 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $1.83 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $61.89 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $3.97 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $9 | $14.04 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $29.12 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $56.96 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.793 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $30.86 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $53.09 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.40 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $10.02 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $15.41 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $79.21 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $77.75 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $29.98 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $5.60 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $547.25 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $3.65 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $85.57 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $1.16 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $44 | $1.10 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $10.34 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.21 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $20 | $18.85 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $14.83 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49 → $75 | $9.50 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $0.8629 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $30.67 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 → $35 | $3.15 | n/a | 3 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $3.99 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $10.17 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $29.80 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.07 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $12.87 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $57.48 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €78.63 | $142.05 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $0.1949 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $115.62 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $13 | $4.38 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $15.61 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $1.94 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $110 | $174.10 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.81 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.83 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $313.04 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $25.33 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $14.51 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $37.39 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.77 | n/a | 1 | Sep 17, 2012 |
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $585
Current: $529.59
Upside: +10.46%
Moderna
Jun 26, 2026
Maintained: Hold
Price Target: $41
Current: $81.80
Upside: -49.88%
Pfizer
Jun 25, 2026
Maintained: Hold
Price Target: $27
Current: $23.72
Upside: +13.83%
Kymera Therapeutics
Jun 25, 2026
Maintained: Buy
Price Target: $120
Current: $114.76
Upside: +4.57%
Merck & Co.
Jun 23, 2026
Maintained: Hold
Price Target: $125
Current: $126.78
Upside: -1.40%
AbbVie
Jun 23, 2026
Maintained: Buy
Price Target: $230
Current: $254.76
Upside: -9.72%
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $125 → $135
Current: $133.50
Upside: +1.12%
Regeneron Pharmaceuticals
Jun 22, 2026
Maintained: Hold
Price Target: $700
Current: $649.81
Upside: +7.72%
Veradermics
Jun 22, 2026
Reiterated: Buy
Price Target: $135
Current: $122.07
Upside: +10.59%
Gilead Sciences
Jun 17, 2026
Maintained: Buy
Price Target: $165
Current: $129.61
Upside: +27.30%
Jun 16, 2026
Maintained: Buy
Price Target: $1,500
Current: $1,200.06
Upside: +24.99%
Jun 11, 2026
Maintained: Buy
Price Target: $55
Current: $24.49
Upside: +124.58%
May 31, 2026
Maintained: Hold
Price Target: $66
Current: $56.70
Upside: +16.40%
May 26, 2026
Maintained: Buy
Price Target: $66
Current: $56.92
Upside: +15.95%
May 10, 2026
Maintained: Buy
Price Target: $130
Current: $131.50
Upside: -1.14%
May 7, 2026
Maintained: Sell
Price Target: $7
Current: $9.35
Upside: -25.13%
May 7, 2026
Maintained: Hold
Price Target: $75
Current: $85.44
Upside: -12.22%
May 7, 2026
Maintained: Buy
Price Target: $58
Current: $55.36
Upside: +4.77%
May 7, 2026
Maintained: Buy
Price Target: $20
Current: $17.97
Upside: +11.30%
May 4, 2026
Rated: Hold
Price Target: $190 → $200
Current: $208.46
Upside: -4.06%
May 1, 2026
Maintained: Hold
Price Target: $345
Current: $366.44
Upside: -5.85%
Apr 29, 2026
Maintained: Buy
Price Target: $50 → $60
Current: $62.77
Upside: -4.41%
Mar 11, 2026
Maintained: Buy
Price Target: $145 → $130
Current: $93.93
Upside: +38.40%
Jan 30, 2026
Maintained: Buy
Price Target: $50
Current: $20.10
Upside: +148.76%
Jan 30, 2026
Maintained: Buy
Price Target: $55
Current: $34.90
Upside: +57.59%
Jan 30, 2026
Maintained: Buy
Price Target: $4
Current: $2.67
Upside: +49.81%
Jun 10, 2024
Maintained: Hold
Price Target: $170
Current: $259.33
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $22
Current: $1.69
Upside: n/a
Jun 4, 2024
Maintained: Buy
Price Target: $130
Current: $58.79
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $1.83
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: $100
Current: $61.89
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $3.97
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $14 → $9
Current: $14.04
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $36
Current: $29.12
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $101
Current: $56.96
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.793
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $30.86
Upside: n/a
Oct 11, 2023
Maintained: Sell
Price Target: n/a
Current: $53.09
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $2.40
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $10.02
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $15.41
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $79.21
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $77.75
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $29.98
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $5.60
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $547.25
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $3.65
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $85.57
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $1.16
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $83 → $44
Current: $1.10
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $10.34
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.21
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $28 → $20
Current: $18.85
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $14.83
Upside: n/a
Oct 8, 2021
Maintained: Hold
Price Target: $49 → $75
Current: $9.50
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $0.8629
Upside: n/a
Mar 19, 2021
Maintained: Buy
Price Target: $35
Current: $30.67
Upside: n/a
Jan 15, 2021
Downgraded: Hold
Price Target: $55 → $35
Current: $3.15
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $70
Current: $3.99
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $10.17
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $29.80
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.07
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $12.87
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $57.48
Upside: n/a
Feb 20, 2020
Maintained: Hold
Price Target: €78.63
Current: $142.05
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $0.1949
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $115.62
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: $13 → $13
Current: $4.38
Upside: n/a
Mar 29, 2019
Maintained: Hold
Price Target: $8
Current: $15.61
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $27
Current: $1.94
Upside: n/a
Mar 28, 2019
Maintained: Buy
Price Target: $103 → $110
Current: $174.10
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $3.81
Upside: n/a
Feb 20, 2019
Maintained: Buy
Price Target: n/a
Current: $6.83
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $313.04
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $25.33
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $14.51
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $37.39
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $9.77
Upside: n/a